Drug for COVID-19 Patients – level 3
A new study conducted by researchers at the University of Albany found that patients, who were hospitalized in the New York area, did not benefit from hydroxychloroquine.
Hydroxychloroquine is the anti-malaria drug which the US president, Donald Trump, repeatedly praised as a possible treatment for the coronavirus. In March, US authorities issued an emergency use authorization to let medical workers use the drug on certain COVID-19 patients.
Researchers looked at more than 1,400 COVID-19 patients, and they found that the patients, who received hydroxychloroquine, did not get better or worse than the patients who did not receive it. The study is not considered conclusive because it did not fulfill all necessary criteria. The state of New York is currently conducting a randomized controlled trial on the drug.
Difficult words: conclusive (proving that something is true), criteria (rules or principles that are used for evaluating or testing something), randomized controlled trial (a study that chooses participants randomly).
You can watch the video news lower on this page.
What do you think about this news?
LEARN 3000 WORDS with NEWS IN LEVELS
News in Levels is designed to teach you 3000 words in English. Please follow the instructions
How to improve your English with News in Levels:
- Do the test at Test Languages.
- Go to your level. Go to Level 1 if you know 1-1000 words. Go to Level 2 if you know 1000-2000 words. Go to Level 3 if you know 2000-3000 words.
- Read two news articles every day.
- Read the news articles from the day before and check if you remember all new words.
- Listen to the news from today and read the text at the same time.
- Listen to the news from today without reading the text.
- Answer the question under today’s news and write the answer in the comments.